Patent · US Active

Spiroindoline compounds for use as anthelminthics

US9598412B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

Intervet Inc. · US

Inventors

Jürgen Lutz · Steinheim, DE
Sandra Koch · Bad Kreuznach, DE
Manfred Uphoff · Bad Kreuznach, DE
Anja Regina Heckeroth · Stadecken-Elsheim, DE
Britta von Oepen · Bad Kreuznach, DE
Ulrich Sondern · Bad Kreuznach, DE
Christophe Pierre Alain Chassaing · Ingelheim am Rhein, DE

Key dates

Filing date	Oct 14, 2014
Grant date	Mar 21, 2017
Priority date	—
Expiry date	Oct 14, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to spiroindoline compounds for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.